SEC 13F Intelligence

Renaissance Technologies LLC / ABT

Renaissance Technologies LLC’s Abbott Laboratories Position

Does Renaissance Technologies LLC own Abbott Laboratories (ABT)? Yes1.24M shares worth $127M (+0.20% of its 13F portfolio) as of Q1 2026, up from 558.1K shares the prior filed quarter.

Position Value
$127M
Q1 2026
Shares
1.24M
% of Portfolio
+0.20%
Quarters Held
15
currently held

Position History ABT

Reported value by quarter
Q2 ’20: $47MQ2 ’20Q1 ’21: $44MQ3 ’21: $28MQ3 ’21Q4 ’21: $221MQ1 ’22: $372MQ1 ’22Q2 ’22: $458MQ3 ’22: $244MQ3 ’22Q4 ’22: $303,522Q1 ’23: $456,386Q1 ’23Q2 ’23: $103,031Q3 ’23: $8,471Q3 ’23Q1 ’24: $95,107Q2 ’24: $162MQ2 ’24Q4 ’25: $70MQ1 ’26: $127MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.24M$127M+0.20%
Q4 2025558.1K$70M+0.11%
Q2 20241.56M$162M+0.28%
Q1 2024836.8K$95,107+0.15%
Q3 202387.5K$8,471+0.01%
Q2 2023945.1K$103,031+0.15%
Q1 20234.51M$456,386+0.61%
Q4 20222.76M$303,522+0.42%
Q3 20222.52M$244M+0.35%
Q2 20224.22M$458M+0.54%
Q1 20223.14M$372M+0.44%
Q4 20211.57M$221M+0.28%
Q3 2021235.2K$28M+0.04%
Q1 2021364.9K$44M+0.05%
Q2 2020516.0K$47M+0.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Renaissance Technologies LLC’s full portfolio or all institutional holders of ABT.